UPDATE: Needham & Company Downgrades Haemonetics (HAE) to Hold
Tweet Send to a Friend
(Updated - January 27, 2022 5:53 AM EST)
Needham & Company analyst Mike Matson downgraded Haemonetics (NYSE: HAE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst Mike Matson downgraded Haemonetics (NYSE: HAE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
